Delivery Order SPE2DB22D2108-SPE2DB24FU2TK
- Not listed
- This federal contract award, valued at $19,624.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies. The contract has a firm fixed price and is a delivery order with an ultimate completion date of August 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,833.70 firm-fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a vaccine product. The award has an ultimate completion date of June 26, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a $3,055.68 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,842.30 for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for the medical product HAVRIX 1,440 UNIT/ML SYRINGE. The $1,837.30 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 29, 2023. The contract is part of a larger, $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award, valued at $10,086.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 26, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,400.64, is a delivery order for the medical product "HAVRIX 1,440 UNIT/ML SYRINGEML". The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $4,034.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. The award covers the procurement of HAVRIX 1,440 UNIT/ML SYRINGE medical supplies, with no set-aside designation indicated. Amerisourcebergen holds a significant...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $3,735.05 firm fixed price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. government awarded a Delivery Order contract worth $2,596.49 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of HAVRIX 1440 UN 1ML 10S, a medical product, to the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU2TKDelivery Order
This federal contract award, valued at $2,927.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML medical supplies, with an ultimate completion date of November 20, 2023. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs worldwide. Additionally, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/17/23 |